Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/17/2025

AmpC β-Lactamase-Producing Organisms

Organisms with Chromosomal AmpC

  • The American Thoracic Society notes that AmpC β-lactamases are produced by specific Enterobacterales species with chromosomal genes, including Enterobacter spp., Citrobacter freundii, Serratia marcescens, Morganella morganii, and Providencia spp. 1
  • Enterobacter species pose the highest risk for treatment failure because they frequently develop high-level constitutive AmpC expression during therapy with third-generation cephalosporins, even when initially susceptible 1

Resistance Pattern

  • AmpC producers demonstrate resistance to all penicillins 1
  • Carbapenems remain the safest option for severe infections caused by AmpC producers, with cefepime serving as an effective carbapenem-sparing alternative due to its stability against AmpC hydrolysis 2

REFERENCES

2

AmpC β-Lactamase Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025